Acorda Therapeutics, Inc. announced that John Varian has joined its board of directors, effective January 1, 2022. Mr. Varian currently serves on the board of directors for AmMax Bio and for Sellas Life Sciences, where he is Chair of the Audit Committee and on its Nominating and Goverance Committee and Science Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.185 USD | -22.92% |
|
-26.00% | -98.77% |
1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+18.17% | 25.93B | |
-24.33% | 19.27B | |
-19.28% | 16.01B | |
-17.95% | 15.66B | |
-46.81% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- ACOR.Q Stock
- ACOR Stock
- News Acorda Therapeutics, Inc.
- Acorda Therapeutics, Inc. Appoints John Varian as Board of Director